Navigation Links
ScienceBased Health Appoints Anne L. Coleman, MD, PhD to Scientific Advisory Board
Date:2/12/2008

CARSON CITY, Nev., Feb. 12 /PRNewswire/ -- ScienceBased Health, a leading provider of evidence-based nutraceuticals for eye health, today announced the appointment of Anne L. Coleman, MD, PhD to its Scientific Advisory Board.

Dr. Coleman is a Professor of Ophthalmology in the Jules Stein Eye Institute of the David Geffen School of Medicine at UCLA as well as Professor of Epidemiology in the UCLA School of Public Health. She holds the Frances and Ray Stark Endowed Chair at UCLA and is Director of the Jules Stein Eye Institute Mobile Eye Clinic. Dr. Coleman received her medical degree from the Medical College of Virginia, completed her fellowship training in glaucoma at the Wilmer Eye Institute, Johns Hopkins University, and received a PhD in Epidemiology from UCLA in 1997.

Dr. Coleman's research is focused on the diagnosis, treatment, and societal impact of glaucoma, cataracts, and age-related macular degeneration (AMD), including the study of lifestyle limitations imposed on patients with these eye diseases. Currently an at-large member of the American Academy of Ophthalmology's Board of Trustees, she is a recipient of the Academy's Senior Achievement Award and Secretariat Award.

"We are honored to welcome Dr. Coleman to the ScienceBased Health Scientific Advisory Board," said Alain Magro, president of ScienceBased Health. "Dr. Coleman brings to the Board a diverse background that will allow her to make significant contributions to our product development and research endeavors. Her expertise in the areas of glaucoma and neuroprotection will be especially valuable."

"I am pleased to be joining the ScienceBased Health Scientific Advisory Board," said Anne L. Coleman, MD, PhD. "I am very interested in the interplay between nutrition and vision and my research interests include the effects of antioxidants on glaucomatous optic nerve damage."

Dr. Coleman joins ScienceBased Health's existing Scientific Advisory Board members: Pau
'/>"/>

SOURCE ScienceBased Health
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Transitions Optical Promotes Healthy Sight Through a Nationwide Integrated Advertising Campaign and the Launch of an Enhanced Consumer Web Site
2. UPMC Health Plan and Heritage Valley Health System Combine Resources in LifeSmart, A Community Initiative Designed to Prevent Diabetes
3. Companion Global Healthcare Adds Hospital in Costa Rica to Overseas Network
4. Methodist Healthcare - Memphis Hospitals Announces the Commencement of the Tender Offer for Certain Designated Maturities of:
5. ACS is Best in KLAS for Healthcare Consulting Services
6. AMN Healthcare Appoints Hala Moddelmog to Its Board of Directors
7. New Survey Shows African-Americans Are Concerned With Heart Health but Unaware of Link to Brain Health
8. HEALTHeCAREERS Network Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
9. Health Care Districts Board Chair Nationally Recognized as a Modern Healthcare Trustee of the Year
10. Office of Administration Extends Retired State Employees Health Benefits Enrollment Period to March 21
11. Home Healthcare Reimbursement Freeze is Barrier to Commonwealth Goal of Advancing Alternative Care

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...wire-USNewswire/ -- At a recently concluded first ...ates came together to outline the future of medica...cessary thrust. Organized by the Medical Tourism A...com , the high-powered congregation of senior mini...s and requests for assistance in medical tourism f...
(Date:12/2/2009).... 2 Lockton Benefit Group is pro...iew on proposed health reform legislation working ...om.com/cgi-bin/prnh/20090415/CG99351LOGO ) ,, F...legislation, according to Ed Fensholt and Mark Hol...iance Services Division and Lockton,s Health Ref...
(Date:12/2/2009)... that affects male urethra, researchers say , ... babies of women who use insect repellents during ...t increased risk for a birth defect called hypospa...which affects about two of every 500 male infants,... tube that carries urine from the bladder to the o...
(Date:12/2/2009)...-risk of breast cancer are well-informed about the...r prevention, only 6 percent said they were likely...Michigan Comprehensive Cancer Center created a dec... and benefits associated with tamoxifen, a drug th...ning and has recently been shown to prevent breast...
(Date:12/2/2009)...ent of low-income mothers who participated in a re...rong general feeling of distrust of the opposite s... not prevent them from entering into a marriage, l... union was often later described by some of the wo...of distrust and insecurity. The results of the stu...
Breaking Medicine News(10 mins):Health News:Ministerial Roundtable Discusses Future of Medical Tourism 2Health News:Ministerial Roundtable Discusses Future of Medical Tourism 3Health News:Lockton Outlines Implications of Proposed Health Reform Plans 2Health News:High-risk women reluctant to take tamoxifen to prevent breast cancer, U-M study finds 2
...r Pharmaceuticals, Inc. (NYSE: BRL ) today confi... has initiated a challenge of the patent listed by...aprine hydrochloride) extended-release capsules, 1...ith the U.S. Food & Drug Administration (FDA),...
...ipients with a serious complication called BK viru... back on anti-rejection drugs reduces the risk of ...ort in the November Clinical Journal of the Ameri...n tapering approaches in BKVAN, an increasingly pr...
...esearchers say, but they don,t know why, , ...g a weekly religious service, regardless of your f...ompared to people who don,t attend services, resea... of terrorism, people are looking for stability, a...
...investigating the best methods for monitoring brai...plane pilots realize when they are operating under...on. , , (Logo: http://www.newscom.com/cgi-bi...y, also know as fNIRS, and other imaging technolog...
...l Rx, the developers of PharmFilm(R) technology an...ng thin film pharmaceutical products, today announ...eith J. Kendall, executive vice president and CFO,...y. , , , Event: 20th Annual Piper Jaffray...
...ts can mean healthier eating without the guilt, ex...ay News) -- A few healthy substitutions in your Th...tent of your food without sacrificing the taste, s... alternatives, you can really help reduce calorie ...
Other Medicine News:Health News:Barr Confirms Patent Challenge of Amrix(R) Extended-Release Capsules, 15mg & 30mg 2Health News:Barr Confirms Patent Challenge of Amrix(R) Extended-Release Capsules, 15mg & 30mg 3Health News:Barr Confirms Patent Challenge of Amrix(R) Extended-Release Capsules, 15mg & 30mg 4Health News:Study compares strategies for BK virus nephropathy 2Health News:Religion May Help Extend Your Life 2Health News:Religion May Help Extend Your Life 3Health News:NASA Conducts Pilot Cognition Studies 2Health News:MonoSol Rx to Present at the 20th Annual Piper Jaffray Health Care Conference 2Health News:Holiday Meals With a Calorie-Conscious Twist 2
(Date:12/2/2009)...PRNewswire-Asia/ -- Simcere Pharmaceutical Group,(...ing pharmaceutical company,specializing in the dev...generic and proprietary pharmaceuticals in China, ... Biological Technology Stock Co., Ltd. ("Jiangsu,Y...cts in order to conduct an,internal inspection and...
(Date:12/1/2009)...ire/ -- Reportlinker.com announces that a new mark...,, Insulin Pumps (External) - A World Market R.../Insulin-Pumps-External---A-World-Market-Review.ht...bcutaneous Insulin Infusion (CSII), provide better...ms of treatment. Insulin pump is a pager-sized bat...
(Date:12/1/2009)...PRNewswire-FirstCall/ -- drugstore.com, inc. (Nasd...beauty, vision, and pharmacy products, today annou...stomer orders were the highest in company history....ty.com web stores featured more special offers th...ion yet. ,, (Logo: http://www.newscom.com/cgi-...
Breaking Medicine Technology:Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 2Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 3Reportlinker Adds Insulin Pumps (External) - A World Market Review 2Reportlinker Adds Insulin Pumps (External) - A World Market Review 3Reportlinker Adds Insulin Pumps (External) - A World Market Review 4drugstore.com, inc. Has Best Day Ever on Cyber Monday 2drugstore.com, inc. Has Best Day Ever on Cyber Monday 3Nanometric butterfly wings created 14415 1Nanometric butterfly wings created 14415 2The Truth About Bad Breath 59249 1The Truth About Bad Breath 59249 2Right Now Sale Leaseback May Be the Only Option to Obtain Cash and a Healthier Balance Sheet 59247 1Right Now Sale Leaseback May Be the Only Option to Obtain Cash and a Healthier Balance Sheet 59247 2Right Now Sale Leaseback May Be the Only Option to Obtain Cash and a Healthier Balance Sheet 59247 3Right Now Sale Leaseback May Be the Only Option to Obtain Cash and a Healthier Balance Sheet 59247 4
.... (NYSE Amex: ILE ) today announced that the Uni...s completed its initial review of the Company,s Bi... Nasolabial Fold/Wrinkles product candidate and th...l review. , , In a communication received from th...mpleted its initial review of the Company,s BLA to...
...ing 24-Hour Ambulatory BP Measures , , PARSIPPANY...y that data presented at the American Society of H...tific Meeting and Exposition (ASH 2009) in San Fra...od Pressure Reductions and C ontrol ( AZTEC ) dem...n medoxomil-based titration regimen provided mean ...
Other Medicine Technology:Food and Drug Administration Accepts Isolagen's Biologics License Application for Full Review 2Food and Drug Administration Accepts Isolagen's Biologics License Application for Full Review 3New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure 2New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure 3New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure 4New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure 5New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure 6New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure 7New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure 8New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure 9
...rade; is a pressure relief mattress overlay design...ow air loss therapy for those patient with skin br...ONS: , Patients whose body weight and size pose a...patient or staff during the performance of routine...
...providing a flexible environment for patient care,... comfort, support, treatment and prevention., ,IN... ,Large patients at risk for pressure ulcers ,Any ...enefit from a pressure reduction surface ,Patients...
Triflex™ II Bariatric Bed
...sty Max 10 Nebulizer W/ 7` CR Resistant Oxygen Tub...times , ,Provide fine particles with a tighter di...les) than conventional nebulizers, ,Our AirLife&t...ers deliver fast and effective treatment more effi...
Medicine Products: